(Q54712657)

English

Cost-effectiveness of administering 13-valent pneumococcal conjugate vaccine in addition to 23-valent pneumococcal polysaccharide vaccine to adults with immunocompromising conditions.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24148572%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Cost-effectiveness of administering 13-valent pneumococcal conjugate vaccine in addition to 23-valent pneumococcal polysaccharide vaccine to adults with immunocompromising conditions (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24148572%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pneumococcal conjugate vaccine

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24148572%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Charles Stoecker

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24148572%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Ruth Link-Gelles

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24148572%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Matthew R Moore

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24148572%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

language of work or name

0 references

publication date

19 October 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24148572%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24148572%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

31

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24148572%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

50

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24148572%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

6011-6021

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24148572%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.024

7 January 2021

Prevention of invasive pneumococcal disease among HIV-infected adults in the era of childhood pneumococcal immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.024

7 January 2021

Cost effectiveness of vaccination against pneumococcal pneumonia: an update

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.024

7 January 2021

Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.024

7 January 2021

The Lifetime Cost of Current Human Immunodeficiency Virus Care in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.024

7 January 2021

Impact of the 2009 influenza pandemic on pneumococcal pneumonia hospitalizations in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.024

7 January 2021

Pneumonia in incident dialysis patients--the United States Renal Data System

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.024

7 January 2021

23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.024

7 January 2021

A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.024

7 January 2021

Defective expression of B7-2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defect

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.024

7 January 2021

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.024

7 January 2021

Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.024

7 January 2021

Uptake of pneumococcal polysaccharide vaccination among working-age adults with underlying medical conditions, United States, 2009.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.024

7 January 2021

The Denver school-based adolescent hepatitis B vaccination program: a cost analysis with risk simulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.024

7 January 2021

Influenza vaccination health impact and cost effectiveness among adults aged 50 to 64 and 65 and older.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.024

7 January 2021

Clinical and economic burden of pneumococcal disease in older US adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.024

7 January 2021

Pneumococcal vaccination of elderly adults: new paradigms for protection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.024

7 January 2021

Vaccination of risk groups in England using the 13 valent pneumococcal conjugate vaccine: economic analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.024

7 January 2021

Cost-effectiveness of adult vaccination strategies using pneumococcal conjugate vaccine compared with pneumococcal polysaccharide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.024

7 January 2021

Prevention of pneumococcal infection with vaccines: an evolving story

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.024

7 January 2021

A Randomized Clinical Trial Comparing Revaccination with Pneumococcal Conjugate Vaccine to Polysaccharide Vaccine among HIV‐Infected Adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.024

7 January 2021

Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.024

7 January 2021

Effectiveness of polysaccharide pneumococcal vaccine in HIV-infected patients: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.024

7 January 2021

A meta-analysis of utility estimates for HIV/AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.024

7 January 2021

Toward consistency in cost-utility analyses: using national measures to create condition-specific values

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.024

7 January 2021

Cost of a quality-adjusted life year in liver transplantation: the influence of the indication and the model for end-stage liver disease score

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.024

7 January 2021

Cost-effectiveness of repeat medical procedures: kidney transplantation as an example.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.024

7 January 2021

Public health and economic impact of the 13-valent pneumococcal conjugate vaccine (PCV13) in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.024

7 January 2021

Identifiers

10.1016/J.VACCINE.2013.10.024

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24148572%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24148572%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54712657&oldid=1402392360"